A University of Texas at Dallas chemist and his colleagues have developed a new chemical reaction that will allow researchers to synthesize selectively the left-handed or right-handed versions of “mirror molecules” found in nature and assess them for potential use against cancer, infection, depression, inflammation and a host of other conditions. The results are important...
Tag: <span>Drug Discovery & Development</span>
Post
High-throughput flow cytometry in drug discovery
SLAS (SOCIETY FOR LABORATORY AUTOMATION AND SCREENING) A new special issue of SLAS Discovery reflects examples of the recent groundswell of creative new applications for high-throughput flow cytometry (HTFC) in drug discovery. IMAGE: HIGH-THROUGHPUT FLOW CYTOMETRY IN DRUG DISCOVERY. Led by guest editors Mei Ding, Ph.D. (AstraZeneca) and Bruce S. Edwards, Ph.D. (University of New Mexico),...
Post
Stages of Drug Discovery & Development
Bio-Rad offers products and services that accelerate the entire drug discovery and development cycle, from target identification through scale-up and manufacturing. Browse our featured resources or request a consultation with one of our Pharma specialists to talk about how Bio-Rad can support your specific needs. TARGET DISCOVERY Whether your targets are proteins, nucleic acids, lipids,...